阿利索尔A通过保护血管内皮细胞来抑制和稳定动脉样硬化斑块
Yang Ma1, Dingzhong Song1, Jie Yuan1
1China State Institute of Pharmaceutical Industry, National Advanced Medical Engineering Research Center, Shanghai, China.
Frontiers in pharmacology
|November 11, 2024
概括
艾利索尔A对血管内皮细胞具有保护作用,抑制动脉样硬化斑块的形成并稳定现有的斑块. 这种天然化合物在减缓这种心血管疾病的进展方面表现有前途.
科学领域:
- 心血管研究研究心血管研究
- 内皮细胞生物学 内皮细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 内皮细胞功能障碍是动脉样硬化发展的关键因素.
- 了解保护机制对于治疗策略至关重要.
- 动脉样硬化涉及复杂的细胞和分子过程.
研究的目的:
- 为了研究阿里索尔A对血管内皮细胞的保护作用.
- 阐明阿里索尔A作用的基本机制.
- 评估阿里索尔A在抑制和稳定动脉样硬化斑块方面的潜力.
主要方法:
- 在ApoE-/-小鼠中的动脉样以及使用人类大动脉内皮细胞 (HAECs) 的体外研究.
- 服用阿里索尔A和血液脂质,大动脉斑块区域和内皮细胞功能 (增殖,迁移,NO分泌,完整性) 的评估.
- 转录组分析和分子对接以确定机制和目标.
主要成果:
- 阿里索尔 在小鼠模型中显著减少了大动脉斑块面积.
- 在体外,alizol A通过抑制增殖,迁移和血管生成来保护HAEC,同时促进NO分泌.
- 转录组学揭示了差异性基因表达,特别是在TNF信号通路中,这表明阿里索尔A准TNF.
结论:
- 阿利索尔A对血管内皮细胞表现出保护作用.
- 艾利索尔A抑制和稳定动脉样硬化斑块,减缓疾病的进展.
- 已确定TNF是阿里索尔A治疗作用的潜在分子标.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
538
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
538
Inflammation
52.8K
Overview
52.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
471
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
471
Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
Antihypertensive Drugs: Vasodilators
479
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
479
Adrenergic Antagonists: ɑ and β-Receptor Blockers
407
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
407


